PeptiDream Inc (PPTDF)
17.00
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
PeptiDream Gross Profit Margin (Quarterly): 89.26% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 89.26% |
| March 31, 2024 | 35.00% |
| December 31, 2023 | 48.45% |
| September 30, 2023 | 78.28% |
| June 30, 2023 | 40.61% |
| March 31, 2023 | 43.30% |
| December 31, 2022 | 80.49% |
| September 30, 2022 | 58.33% |
| June 30, 2022 | 43.23% |
| March 31, 2022 | -18.12% |
| December 31, 2021 | 55.76% |
| September 30, 2021 | 85.27% |
| June 30, 2021 | 45.53% |
| March 31, 2021 | 62.96% |
| December 31, 2020 | 89.03% |
| September 30, 2020 | 43.13% |
| June 30, 2020 | 80.24% |
| March 31, 2020 | 13.97% |
| September 30, 2019 | 18.43% |
| June 30, 2019 | 83.63% |
| March 31, 2019 | 66.02% |
| December 31, 2018 | 75.85% |
| Date | Value |
|---|---|
| September 30, 2018 | 48.32% |
| June 30, 2018 | 87.21% |
| March 31, 2018 | -49.24% |
| December 31, 2017 | 53.62% |
| September 30, 2017 | -147.4% |
| June 30, 2017 | 80.94% |
| March 31, 2017 | 10.39% |
| December 31, 2016 | 37.31% |
| September 30, 2016 | 69.94% |
| June 30, 2016 | 74.14% |
| March 31, 2016 | 83.56% |
| December 31, 2015 | 68.00% |
| September 30, 2015 | 52.94% |
| June 30, 2015 | 81.85% |
| March 31, 2015 | 15.01% |
| December 31, 2014 | 51.90% |
| September 30, 2014 | 11.15% |
| June 30, 2014 | 63.25% |
| March 31, 2014 | 34.89% |
| December 31, 2013 | 74.22% |
| September 30, 2013 | 57.90% |
| June 30, 2013 | 52.93% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-18.12%
Minimum
Mar 2022
89.26%
Maximum
Jun 2024
54.15%
Average
52.11%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 66.47% |
| Nxera Pharma Co Ltd | 78.44% |
| Healios KK | 86.35% |
| AnGes Inc | 31.07% |
| SanBio Co Ltd | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 51.02% |
| Return on Assets | 29.47% |
| Return on Invested Capital | 34.00% |
| Profit Margin (Quarterly) | 58.82% |
| Operating Margin (Quarterly) | 80.69% |
| Return on Net Operating Assets | 50.26% |